18F‐FDG PET‐CT Scans in Oncology Patients Treated with Hyaluronic Acid Filler: Not Always a Pitfall
The use of hyaluronic acid (HA) fillers in oncology patients undergoing PET‐CT scans is a topic of debate due to potential interference with imaging accuracy. A 54‐year‐old female, postmelanoma metastasectomy in the parotid region with subsequent facial nerve palsy (FNP), received HA filler injections for facial symmetry and functional restoration ...
Ilaria Proietti+8 more
wiley +1 more source
Exploring Vanilla U-Net for Lesion Segmentation from Whole-body FDG-PET/CT Scans [PDF]
Tumor lesion segmentation is one of the most important tasks in medical image analysis. In clinical practice, Fluorodeoxyglucose Positron-Emission Tomography~(FDG-PET) is a widely used technique to identify and quantify metabolically active tumors. However, since FDG-PET scans only provide metabolic information, healthy tissue or benign disease with ...
arxiv
Domain-adapted large language models for classifying nuclear medicine reports [PDF]
With the growing use of transformer-based language models in medicine, it is unclear how well these models generalize to nuclear medicine which has domain-specific vocabulary and unique reporting styles. In this study, we evaluated the value of domain adaptation in nuclear medicine by adapting language models for the purpose of 5-point Deauville score ...
arxiv
Objective: To retrospectively evaluate contribution of F-18 fluorodeoxyglucose positron-emission tomography/computed tomography (18FDG-PET/CT) to re-staging of upper urinary tract urothelial carcinoma (UTUC). Materials and Methods: This study included a
Hakan Öztürk
doaj +1 more source
Comparison of (18)F SPECT with PET in myocardial imaging: A realistic thorax-cardiac phantom study [PDF]
BACKGROUND: Positron emission tomography (PET) imaging with fluorine-18 ((18)F) Fluorodeoxyglucose (FDG) and flow tracer such as Rubidium-82 ((82)Rb) is an established method for evaluating an ischemic but viable myocardium. However, the high cost of PET
E Skoufis+25 more
core +2 more sources
Cerebrospinal Fluid Tau Protein Levels and F-18-Fluorodeoxyglucose Positron Emission Tomography in the Differential Diagnosis of Alzheimer's Disease [PDF]
Aims: In this study, we aimed to compare cerebrospinal fluid (CSF) levels of total tau (t-tau), phosphorylated tau (p-tau(181)) and positron emission tomography with F-18-fluorodeoxyglucose (FDG-PET) in the differential diagnosis of Alzheimer's disease ...
Bartenstein, Peter+7 more
core +1 more source
CA: A Cancer Journal for Clinicians, Volume 74, Issue 4, Page 323-338, July/August 2024.
Edouard H. Nicaise+8 more
wiley +1 more source
The role of PET-CT in radiotherapy planning of solid tumours [PDF]
PET-CT is becoming more and more important in various aspects of oncology. Until recently it was used mainly as part of diagnostic procedures and for evaluation of treatment results.
Jelerčič, Staša, Rajer, Mirjana
core +2 more sources
Survival analysis, the infinite Gaussian mixture model, FDG-PET and non-imaging data in the prediction of progression from mild cognitive impairment [PDF]
We present a method to discover interesting brain regions in [18F] fluorodeoxyglucose positron emission tomography (PET) scans, showing also the benefits when PET scans are in combined use with non-imaging variables. The discriminative brain regions facilitate a better understanding of Alzheimer's disease (AD) progression, and they can also be used for
arxiv
role of f18 fdg pet ct in restaging patients affected by renal carcinoma [PDF]
ACKGROUND: Renalcancers account for around 3% of all cancers and the most common type of (90%) is renal cell carcinoma Five-year survival rate in renal cancer patients is 68.4%.
Alessandro Antonelli+10 more
core +2 more sources